Consequently, the increase release of the biotin-fragment from the avidin-modified MMP2 peptide used in the present study after its cleavage in the tumor could potentially represent an attractive target for avidin-conjugated nanoparticles containing a therapeutic agent. This evidence concerns the gene MMP2 and neoplasm.